Cite

HARVARD Citation

    Zhu, P. et al. (2018). Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo. RSC advances. 8 (46), pp. 25909-25919. [Online]. 
  
Back to record